Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001641172-25-010854
Filing Date
2025-05-15
Accepted
2025-05-15 16:05:50
Documents
5
Effectiveness Date
2025-05-15

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 104569
2 EX-5.1 ex5-1.htm EX-5.1 13070
3 EX-23.1 ex23-1.htm EX-23.1 3882
4 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 17391
5 GRAPHIC ex5-1_001.jpg GRAPHIC 7033
  Complete submission text file 0001641172-25-010854.txt   149877
Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734
Business Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-287311 | Film No.: 25952720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)